Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Stocks - Best Buy, Pfizer Climb Premarket; Snap Drops

Published 2020-07-22, 07:57 a/m
Updated 2020-07-22, 07:57 a/m
© Reuters.

© Reuters.

By Peter Nurse 

Investing.com -- Stocks in focus in premarket trade on Wednesday, July 22nd. Please refresh for updates.

  • Snap (NYSE:SNAP) stock dropped 6.6% after the social media company said late Tuesday that its bump in user growth at the start of coronavirus-led lockdowns petered out sooner than expected, and it’s also forecasting fewer daily active users this quarter than it previously forecast.

  • United Airlines (NASDAQ:UAL) stock fell 0.6% after the troubled airline reported a $1.6 billion loss in the second quarter, with a $40 million a day cash burn, calling the quarter “the most difficult” financial period in its 94-year history. 

  • Best Buy (NYSE:BBY) stock rose 5.2% after the retailer reported late Tuesday that its quarter-to-date sales rose about 2.5%, driven by a surge in online shopping for electronic devices and appliances.

  • Capital One (NYSE:COF) stock fell 3.3% after the credit card company reported a net loss in the second quarter after setting aside a higher provision for credit losses due to the Covid-19 pandemic.

  • Texas Instruments (NASDAQ:TXN) stocks rose 1.6% after the chip maker's earnings topped estimates in the second quarter, and forecast a strong following quarter as the number of people working from home boosts demand for PCs, tablets and servers.

  • Pfizer (NYSE:PFE) stock rose 4.7% and Biontech (NASDAQ:BNTX) climbed 6.7% after announcing an agreement with the U.S. government to supply an initial order of 100 million doses of its Covid-19 vaccine candidate for $1.95 billion.

  • FirstEnergy (NYSE:FE) stock dropped 7%, continuing Tuesday’s 17% plunge, after the company was linked to a bribery scandal which has resulted in the arrests of senior political figures in Ohio.

  • Biogen (NASDAQ:BIIB) stock rose 2.1% after posting a 3.2% rise in second-quarter profit, getting a lift from demand for its top-selling multiple sclerosis drug Tecfidera.

  • Tesla (NASDAQ:TSLA) stock rose 1.2% ahead of its second-quarter results, due ahead of the bell. CEO Elon Musk has qualified for a $2.1 billion payout after the company’s six-month average market capitalization reached $150 billion.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.